Last updated: 2026-09-06 18:27:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
QuidelOrtho Corporation (QDEL) operates in the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector and is listed on NASDAQ. The stock is currently priced at $13.97, with a market capitalisation of $956.63M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $9.92 to $35.58. This page covers its latest market performance, valuation, price trends and company information.
$956.63M | |
$13.92 | |
$306.72 | |
$3.00 | |
$13.93 | |
720.12K | |
-- | |
-- | |
$35.58 | |
$9.92 | |
-- | |
-- |
QuidelOrtho Corporation (QDEL) last closed at $13.93 as of 2026-09-04 23:31:00, unchanged from the previous close of $13.93.
During the latest regular trading session, QDEL traded between $3.00 and $306.72, with a volume of 720.12K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, QuidelOrtho Corporation (QDEL) moved from $14.60 to $13.97, representing a decline of 4.32% ($0.63).
The stock traded between $13.52 and $14.28 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 918.13 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 15.8%
QDEL is currently trading at $13.97, placing it 15.8% of the way from its 52-week low of $9.92 to its 52-week high of $35.58. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.
| Industry | IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES |
| Employees | 6500 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of QuidelOrtho Corporation (QDEL) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.